| Old Articles: <Older 971-980 Newer> |
 |
Bio-IT World January 12, 2004 Anthony Strattner |
Regulatory Compliance Follow this program to avoid drug marketing and pricing violations.  |
Bio-IT World January 12, 2004 |
PDMA Compliance in 12 Steps Prescription Drug Marketing Act violations can cost millions. To save that money, follow this program.  |
Bio-IT World January 12, 2004 Bob Violino |
What's the Problem? Validating computer systems is unavoidable. Here's how to pass FDA inspections while minimizing validation time and cost.  |
Bio-IT World January 12, 2004 Steve Lefar |
Systematize Your Regulatory Info! Want better protection against regulation breaches? Build a system that engenders 'grassroots' compliance.  |
Bio-IT World January 12, 2004 Kevin Davies |
The Ultimate Platform Firm Greg Lucier on determinism in drug development at Invitrogen  |
Bio-IT World January 12, 2004 Pauline Parry |
The Code Breakers Ambrx tinkers with the building blocks of life  |
Bio-IT World January 12, 2004 Simon Smyth |
Forecasting the Future for Pharma The environment confronting the pharmaceutical and biotechnology industry is harsh indeed, as cut-throat competition, regulatory restraint, patent expiries on major products, and healthcare cost-containment measures all conspire to constrain revenue and profit growth.  |
Bio-IT World January 12, 2004 Michael A. Greeley |
What You See Is What You Get Better image analysis, better business models. The transition from analog to digital will allow systems biology to reach its full potential.  |
IndustryWeek January 1, 2004 John S. McClenahen |
Expanding The Discovery Channel Additional R&D labs at AstraZeneca in Waltham, Mass., promise to aid in development of cancer and infectious disease drugs.  |
BusinessWeek January 12, 2004 |
Health Care: The Patient Will Live, But... Employers and consumers will continue to get hammered by rising premiums, but health-care costs will rise a bit more slowly, which is good news for insurers.  |
| <Older 971-980 Newer> Return to current articles. |